WallStreetZenWallStreetZen

NASDAQ: VNDA
Vanda Pharmaceuticals Inc Stock Ownership - Who owns Vanda Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Vanda Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mihael Hristos PolymeropoulosPresident and CEO2025-08-0710,000$4.15
$41.50kBuy
Stephen Ray MitchellDirector2025-06-137,000$4.59
$32.13kSell
Mihael Hristos PolymeropoulosPresident and CEO2025-05-219,519$4.40
$41.88kBuy
Mihael Hristos PolymeropoulosPresident and CEO2025-05-21481$4.39
$2.11kBuy
Mihael Hristos PolymeropoulosPresident and CEO2025-05-1620,000$4.22
$84.48kBuy
Mihael Hristos PolymeropoulosPresident and CEO2025-03-065,000$5.01
$25.05kBuy
Mihael Hristos PolymeropoulosPresident and CEO2025-03-065,000$5.02
$25.10kBuy
Mihael Hristos PolymeropoulosPresident and CEO2025-03-055,000$5.01
$25.05kBuy
Mihael Hristos PolymeropoulosPresident and CEO2025-03-055,000$5.03
$25.15kBuy
Mihael Hristos PolymeropoulosPresident and CEO2025-03-0310,000$4.71
$47.05kBuy

1 of 3

VNDA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VNDA insiders and whales buy or sell their stock.

VNDA Shareholders

What type of owners hold Vanda Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc15.97%9,435,626$42.55MInstitution
James E. Flynn14.67%8,669,076$39.10MInsider
Vanguard Group Inc6.05%3,572,803$16.11MInstitution
Renaissance Technologies LLC5.83%3,447,460$15.55MInstitution
Millennium Management LLC5.28%3,120,339$14.07MInstitution
Kevin C. Tang4.60%2,715,852$12.25MInsider
Dimensional Fund Advisors LP4.38%2,585,757$11.66MInstitution
Rho Ventures IV LP4.26%2,518,177$11.36MInsider
Tang Capital Management LLC3.98%2,353,307$10.61MInstitution
Mihael Hristos Polymeropoulos3.95%2,335,731$10.53MInsider

1 of 3

VNDA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VNDA52.49%47.51%Net SellingNet Buying
CTNM49.41%9.63%Net Selling
NGNE46.33%53.67%Net Buying
VOR45.02%48.14%Net Selling
LCTX39.05%60.95%Net Buying
View Top Biotech Stocks

Vanda Pharmaceuticals Stock Ownership FAQ

Who owns Vanda Pharmaceuticals?

Vanda Pharmaceuticals (NASDAQ: VNDA) is owned by 76.15% institutional shareholders, 68.92% Vanda Pharmaceuticals insiders, and 0.00% retail investors. James E. Flynn is the largest individual Vanda Pharmaceuticals shareholder, owning 8.67M shares representing 14.67% of the company. James E. Flynn's Vanda Pharmaceuticals shares are currently valued at $41.18M.

If you're new to stock investing, here's how to buy Vanda Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.